Latest News and Press Releases
Want to stay updated on the latest news?
-
Manufacturing operations divestiture sharpens focus on core capabilities in novel drug discovery and developmentManufacturing divestiture and expanded monetization of ZYNYZ royalty anticipated to...
-
Reaffirms guidance to resubmit Anaphylm™ (dibutepinephrine) sublingual film NDA in Q3 2026Affirms existing clinical data is sufficient for submitting regulatory applications in Canada, European Union,...
-
Gabelli Global Small and Mid Cap Value Trust Declares Second Quarter Distribution of $0.21 Per Share
RYE, N.Y., May 13, 2026 (GLOBE NEWSWIRE) -- The Board of Trustees of The Gabelli Global Small and Mid Cap Value Trust (NYSE:GGZ) (the “Fund”) declared a $0.21 per share cash distribution payable on...
-
Issued on behalf of Western Star Resources Inc. A CMETC-eligible flow-through financing, a €200,000 European IR mandate, and a DIBC application land in the same week — under eight months before the...
-
PharmAla announces signed definitive agreement to form a special purpose vehicle to spin out APA-01 entity for development, partnering with Diteba
-
SS Innovations Reports First Quarter 2026 Financial Results
-
New York, May 13, 2026 (GLOBE NEWSWIRE) -- Diamond Equity Research, an equity research firm with a focus on small capitalization public companies has released an Update Note on Almonty Industries,...
-
- Three patients treated with ZEVASKYN® in Q1 2026 - - QTC network expands to six sites, with two new additions on the East Coast - - In-licensed radically novel engineered T-cell technology with...
-
Revenue grew approximately 35% year-over-year to $15.5 million for Q1 2026 Net income increased by over 100% year-over-year to $2.3 million for Q1 2026 Adjusted EBITDA for Q1 of 2026 more than...
-
WINNIPEG, Manitoba, May 13, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) announced today its participation in the World Council of Enterostomal...